Luciferase Reporter Cell Line - Nthy-ori 3-1

The Nthy-ori 3-1 cell line is a non-tumorigenic model derived from primary human thyroid follicular epithelial cells. To enable continuous long-term laboratory culture, these cells were immortalized using a plasmid containing the SV40 large T-antigen. Despite this genetic modification, they maintain a standard adherent, epithelial morphology and retain the essential biological characteristics of healthy, functional thyroid cells. The Luciferase Reporter Cell Line - Nthy-ori 3-1 is an advanced derivative engineered to stably express the firefly luciferase enzyme. Because this gene is stably integrated into the genome, the modified cells continuously emit a quantifiable bioluminescent signal upon exposure to the substrate luciferin. This transforms a standard physiological thyroid model into a highly sensitive tool that provides reliable luminescence across multiple passages without altering foundational cellular behaviors.

Building on this physiological relevance, this reporter cell line is heavily utilized for both high-throughput in vitro assays and real-time in vivo imaging. The standard parent line acts as a critical benchmark for normal thyroid behavior, frequently used to study autoimmune thyroid conditions, iodine metabolism, and cellular responses to endocrine disruptors. The luciferase modification specifically enables the non-invasive tracking of cell viability and proliferation. When implanted into animal models, researchers can continuously monitor the cells' location and survival over time without requiring multiple end-point sacrifices. In vitro, the model accelerates toxicological and pharmacological screening; scientists can rapidly quantify the cytotoxic impact of novel drug candidates or environmental toxins on normal human thyroid tissue simply by measuring the resulting bioluminescent signal intensity.